ProShare Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

ProShare Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,372	Closed	-$389K	–	2134
2024 Q2	$389K	Buy	+14,372	New	+$299K	﹤0.01%	1120
2023 Q1	–	Sell	-4,828	Closed	-$255K	–	1929
2022 Q4	$255K	Buy	+4,828	New	+$235K	﹤0.01%	1328
2022 Q2	–	Sell	-6,439	Closed	-$266K	–	2188
2022 Q1	$266K	Sell	6,439 -1,062	-14%	-$37.4K	﹤0.01%	1716
2021 Q4	$320K	Buy	7,501 +3,155	+73%	+$158K	﹤0.01%	1747
2021 Q3	$239K	Sell	4,346 -4,453	-51%	-$233K	﹤0.01%	1698
2021 Q2	$421K	Buy	8,799 +1,503	+21%	+$76.6K	﹤0.01%	1660
2021 Q1	$370K	Buy	7,296 +1,248	+21%	+$69.4K	﹤0.01%	1668
2020 Q4	$381K	Buy	6,048 +2,751	+83%	+$171K	﹤0.01%	1438
2020 Q3	$222K	Buy	+3,297	New	+$180K	﹤0.01%	1361

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ProShare Advisors's SILK Position: Q3 2024 in Review

ProShare Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 14,372 shares — an estimated $389K sold.

ProShare Advisors first reported a position in SILK in Q3 2020 and held it in 9 quarters. The position peaked at $421K in Q2 2021. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

ProShare Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
ProShare Advisors sold 14,372 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $389K.
ProShare Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
ProShare Advisors's Silk Road Medical, Inc. Common Stock position peaked at $421K in Q2 2021.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.